173 related articles for article (PubMed ID: 17428784)
21. Generation and characterization of a novel CYP2A13--transgenic mouse model.
Jia K; Li L; Liu Z; Hartog M; Kluetzman K; Zhang QY; Ding X
Drug Metab Dispos; 2014 Aug; 42(8):1341-8. PubMed ID: 24907355
[TBL] [Abstract][Full Text] [Related]
22. CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody.
Zhu LR; Thomas PE; Lu G; Reuhl KR; Yang GY; Wang LD; Wang SL; Yang CS; He XY; Hong JY
Drug Metab Dispos; 2006 Oct; 34(10):1672-6. PubMed ID: 16815959
[TBL] [Abstract][Full Text] [Related]
23. p-dimethylaminocinnamaldehyde derivatization for colorimetric detection and HPLC-UV/vis-MS/MS identification of indoles.
Porubsky PR; Scott EE; Williams TD
Arch Biochem Biophys; 2008 Jul; 475(1):14-7. PubMed ID: 18423367
[TBL] [Abstract][Full Text] [Related]
24. Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine.
DeVore NM; Meneely KM; Bart AG; Stephens ES; Battaile KP; Scott EE
FEBS J; 2012 May; 279(9):1621-31. PubMed ID: 22051186
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of nicotine and cotinine by human cytochrome P450 2A13.
Bao Z; He XY; Ding X; Prabhu S; Hong JY
Drug Metab Dispos; 2005 Feb; 33(2):258-61. PubMed ID: 15528319
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.
Stephens ES; Walsh AA; Scott EE
Drug Metab Dispos; 2012 Sep; 40(9):1797-802. PubMed ID: 22696418
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of CYP2A6 and CYP2A13 during nicotine metabolism.
von Weymarn LB; Brown KM; Murphy SE
J Pharmacol Exp Ther; 2006 Jan; 316(1):295-303. PubMed ID: 16188955
[TBL] [Abstract][Full Text] [Related]
28. Insight into the Interaction Mechanism of Nicotine, NNK, and NNN with Cytochrome P450 2A13 Based on Molecular Dynamics Simulation.
Neves Cruz J; Santana de Oliveira M; Gomes Silva S; Pedro da Silva Souza Filho A; Santiago Pereira D; Lima E Lima AH; de Aguiar Andrade EH
J Chem Inf Model; 2020 Feb; 60(2):766-776. PubMed ID: 31622091
[TBL] [Abstract][Full Text] [Related]
29. Structure-Function Studies of Naphthalene, Phenanthrene, Biphenyl, and Their Derivatives in Interaction with and Oxidation by Cytochromes P450 2A13 and 2A6.
Shimada T; Takenaka S; Kakimoto K; Murayama N; Lim YR; Kim D; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
Chem Res Toxicol; 2016 Jun; 29(6):1029-40. PubMed ID: 27137136
[TBL] [Abstract][Full Text] [Related]
30. CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline.
Fukami T; Nakajima M; Sakai H; Katoh M; Yokoi T
Drug Metab Dispos; 2007 Mar; 35(3):335-9. PubMed ID: 17178771
[TBL] [Abstract][Full Text] [Related]
31. Newly Identified Tree Shrew
Ushirozako G; Noda Y; Murayama N; Kawaguchi H; Tsukiyama-Kohara K; Yamazaki H; Uno Y
Drug Metab Dispos; 2023 May; 51(5):610-617. PubMed ID: 36669854
[TBL] [Abstract][Full Text] [Related]
32. Molecular modelling of CYP2A enzymes: application to metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Jalas JR; Seetharaman M; Hecht SS; Murphy SE
Xenobiotica; 2004 Jun; 34(6):515-33. PubMed ID: 15277013
[TBL] [Abstract][Full Text] [Related]
33. Roles of Human CYP2A6 and Monkey CYP2A24 and 2A26 Cytochrome P450 Enzymes in the Oxidation of 2,5,2',5'-Tetrachlorobiphenyl.
Shimada T; Kakimoto K; Takenaka S; Koga N; Uehara S; Murayama N; Yamazaki H; Kim D; Guengerich FP; Komori M
Drug Metab Dispos; 2016 Dec; 44(12):1899-1909. PubMed ID: 27625140
[TBL] [Abstract][Full Text] [Related]
34. Suppression of pulmonary CYP2A13 expression by carcinogen-induced lung tumorigenesis in a CYP2A13-humanized mouse model.
Liu Z; Megaraj V; Li L; Sell S; Hu J; Ding X
Drug Metab Dispos; 2015 May; 43(5):698-702. PubMed ID: 25710941
[TBL] [Abstract][Full Text] [Related]
35. The missense genetic polymorphisms of human CYP2A13: functional significance in carcinogen activation and identification of a null allelic variant.
Wang SL; He XY; Shen J; Wang JS; Hong JY
Toxicol Sci; 2006 Nov; 94(1):38-45. PubMed ID: 16917071
[TBL] [Abstract][Full Text] [Related]
36. Nicotine Component of Cigarette Smoke Extract (CSE) Decreases the Cytotoxicity of CSE in BEAS-2B Cells Stably Expressing Human Cytochrome P450 2A13.
Ji M; Zhang Y; Li N; Wang C; Xia R; Zhang Z; Wang SL
Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29027939
[TBL] [Abstract][Full Text] [Related]
37. Optimization of heme precursors for the expression of human cytochrome P450 2A13 and its co-expression with oxidoreductase in baculovirus/sf9 system.
Lu HY; Qiu LL; Yang XJ; Zhang XM; Zhang Z; Wang SL
J Biochem; 2013 Jun; 153(6):555-63. PubMed ID: 23463547
[TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationship and
Boonruang S; Prakobsri K; Pouyfung P; Prasopthum A; Rongnoparut P; Sarapusit S
Xenobiotica; 2020 Jun; 50(6):630-639. PubMed ID: 31578905
[TBL] [Abstract][Full Text] [Related]
39. Nicotine Inhibits the Cytotoxicity and Genotoxicity of NNK Mediated by CYP2A13 in BEAS-2B Cells.
Sun Y; Wang H; Chen H; Zhang S; Li J; Zhang J; Tian J; Zhang Y; Hou H; Hu Q
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956805
[TBL] [Abstract][Full Text] [Related]
40. Genetic and Enzymatic Characteristics of CYP2A13 in Relation to Lung Damage.
Vrzal R
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
